Author Affiliations: University of Rochester School of Medicine and Dentistry (Ms Venkateswaran) and Department of Pathology and Laboratory Medicine (Dr Yeaney) and Flaum Eye Institute (Dr Hindman), University of Rochester School of Medicine and Dentistry, Rochester, New York.
Epithelial downgrowth is a rare but grave complication of intraocular surgery1,2 that typically manifests as epithelial sheets, cysts, or pearls.1- 4 Prognosis is poor as incursion of epithelial cells onto anterior chamber structures can result in corneal decompensation, refractory glaucoma, and visual deficits.2 Treatment options include enucleation, surgical excision, irradiation, cryotherapy, cautery, laser coagulation, vitrectomy, and injections of antimetabolites.1- 5 Herein, we describe a case in which epithelial downgrowth appeared as an amorphous anterior chamber cellular aggregate, was diagnosed by anterior chamber tap and specular microscopy, and was treated successfully with fluorouracil.
A 66-year-old woman who had been receiving subconjunctival steroid injections for presumed graft rejection visited in December 2009 with decreased vision in her right eye. Her ocular history included Fuchs endothelial dystrophy and narrow-angle glaucoma. Her right eye had undergone penetrating keratoplasty, cataract extraction, and anterior chamber intraocular lens implantation in November 2006 and pars plana vitrectomy and pars plana Ahmed tube shunt in October 2008.
Examination of the right eye revealed best-corrected visual acuity of 20/150. Intraocular pressure measured less than 5 mm Hg. Slitlamp examination revealed a resolving subconjunctival hemorrhage as well as a pink, fibrous plaque on the anterior surface of the anterior chamber intraocular lens (Figure 1A). The vitreous and retina were normal. Five days later, the plaque resolved without additional intervention. Subsequently, the patient developed a pupillary membrane and inflammatory, “fluffy,” white debris accumulated in the anterior chamber (Figure 1B).
Figure 1. Clinical photographs. A, Pink, fibrous plaque (asterisk) on the anterior surface of the anterior chamber intraocular lens. B, Inflammatory, white, “fluffy” debris (arrow) free floating in the anterior chamber. Inset, Greater magnification of the debris. C, Specular microscopy findings, with the left panel demonstrating guttae characteristic of Fuchs endothelial dystrophy and the right panel demonstrating an amorphous pattern with larger cells and hyperreflective nuclei. Arrows indicate cells suggestive of epithelial cells (original magnification ×230). D, Complete resolution of the inflammatory or epithelial anterior chamber debris.
Findings on review of systems and a systemic workup for anterior uveitis were negative. Anterior chamber taps were performed for stains, cultures, polymerase chain reaction, and pathological analysis. Gram stains showed 10 to 25 mononuclear cells per low-power field but no organisms. Fungal stains and bacterial and fungal cultures were negative. Results of polymerase chain reaction were negative for herpes simplex virus, herpes zoster virus, and cytomegalovirus. Cytological analysis showed no morphologic evidence of lymphoid neoplasia. However, degenerating neutrophils and macrophages along with epithelioid nonhematopoietic cells consistent with epithelial downgrowth were identified (Figure 2A). An amorphous pattern of larger cells with hyperreflective nuclei suggestive of epithelial cells was seen on specular microscopy6 (Figure 1C).
Figure 2. Histopathological analysis. A, Cytologic preparation from anterior chamber aspirates. Arrows indicate mononuclear epithelioid cells with abundant cytoplasm (Wright Giemsa). B-D, Histopathological specimens from the retrocorneal membrane. B, Descemet membrane and fibrous, retrocorneal membrane (hematoxylin-eosin). C, Diffuse positive staining with smooth muscle actin. D, Diffuse positive staining with CK7.
The anterior chamber debris was removed with aspiration and the patient was treated twice with intracameral injections of fluorouracil, 1000 μg/0.1 mL, in a dispersive viscoelastic4 with complete resolution of the anterior chamber findings. The patient required a repeated penetrating keratoplasty for graft failure that transpired during the course of her treatment. Three months postoperatively, uncorrected visual acuity was 20/40. No recurrence of epithelial or inflammatory anterior chamber debris has occurred (Figure 1D).
The Descemet membrane separated from the overlying stroma intraoperatively. Histopathological analysis did not reveal a migratory path of epithelial cells, although the specimen lacked the complete graft-host junction. A fibrous retrocorneal membrane (Figure 2B) was identified and subsequently classified to be of metaplastic endothelial origin based on Jakobiec and Bhat's established classification of retrocorneal membranes7 (Figure 2C and D).
This case illustrates an unusual manifestation of epithelial downgrowth as an amorphous cellular aggregate within the aqueous as opposed to more typical manifestations of epithelial sheets, cysts, or pearls. Our diagnosis was based on the histopathological results of the aqueous tap and specular microscopy. The mechanism of entry of the ectopic epithelial cells remains unclear, but possibilities include entry through the corneal wound during the triple procedure or retrograde flow through the tube. Importantly, epithelial downgrowth should be considered in the differential diagnosis of chronic anterior chamber inflammation and cellular aggregates that are unresponsive to therapy.
In our case, fluorouracil treatment achieved excellent anatomical and visual results. Two cases in 2002 documented the complete resolution of epithelial downgrowth in patients treated with fluorouracil4,5; however, neither case showed post–fluorouracil treatment histopathological correlates. Our patient's eye remains devoid of any ectopic epithelial cells, but her initial graft failed after a retrocorneal membrane had developed. The retrocorneal membrane may have resulted from metaplastic endothelial cell growth due to deposition of hematopoietic or epithelial cells in the anterior chamber, metaplasia of existing endothelial cells, or a reaction between the fluorouracil and epithelial cells.7
Correspondence: Dr Hindman, Flaum Eye Institute, 601 Elmwood Ave, Box 659, Rochester, NY 14642 (email@example.com).
Author Contributions: Dr Hindman had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was supported by grant K23EY019353 from the National Eye Institute, National Institutes of Health.
Additional Contributions: Flaum Eye Institute's Diagnostic Imaging Service obtained the clinical images.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.